Teva Pharmaceutical Industries Limited (TEVA)Healthcare | Drug Manufacturers - Specialty & Generic | Tel Aviv-Yafo, Israel | NYSE
32.40 USD
+1.14
(3.647%)
⇧
(April 17, 2026, 4 p.m.
EDT)
Short-term: ★★★★☆ | Long-term: ★★★☆☆ | Dividends: ★★☆☆☆ |
Hot Take | April 18, 2026, 10:09 p.m. EDT
Teva presents a high-conviction short-term momentum play as the market begins pricing in the success of its Duvakitug pipeline and biosimilar wins, pushing the 12-parameter forecast to a 'strong buy' despite recent price dips. While long-term valuation based on forward P/E (10.4x) remains attractive, the lack of dividend history and high debt-to-equity (217%) limit its appeal as a defensive compounder. Speculator positioning confirms a 'fly to the upside' bias, with options writers aggressively pricing in a stop-loss scenario below $26 rather than a reversion to the mean. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.062118 |
| AutoETS | 0.062270 |
| AutoTheta | 0.140742 |
| AutoARIMA | 0.269782 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 65% |
| H-stat | 1.60 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.197 |
| Excess Kurtosis | -1.31 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2017-11-26 |
| Last Dividend Date | 2017-11-26 |
| Debt to Equity Ratio | 217.715 |
| Revenue per Share | 15.072 |
| Market Cap | 38,652,448,768 |
| Trailing P/E | 26.78 |
| Forward P/E | 10.40 |
| Beta | 0.76 |
| Profit Margins | 8.17% |
| Website | https://www.tevapharm.com |
As of April 18, 2026, 10:09 p.m. EDT: Options flow reveals a mixed but moderately bullish speculative sentiment. In the near term (April 17), there is notable volume at the 34.5 strike (+6.5% vol/OI ratio), suggesting a move toward 10–12% upside, while the 20.0 strike shows a massive IV spike implying heavy protection buying at extreme downside. The bullish lean extends into May, where long-dated OTM calls (34–36 strikes) show significant new volume. However, put sides consistently display major OI walls at 26 (Apr), 26–29 (May), and 23–30 (Jun), indicating key support levels where speculators are betting on a decline or hedging down-side risk. The implied volatility surfaces show higher IV for deep OTM calls compared to OTM puts in June+, confirming a mild bullish skew in expectations over the next 3-6 months.
| Date | Dividend | Yield % |
|---|---|---|
| 2017-11-27 | 0.085000 | 0.580205 |
| 2017-08-25 | 0.085000 | 0.527641 |
| 2017-06-01 | 0.340000 | 1.185486 |
| 2017-02-28 | 0.340000 | 0.994170 |
| 2016-12-01 | 0.340000 | 0.961174 |
| 2016-08-18 | 0.340000 | 0.668615 |
| 2016-05-20 | 0.340000 | 0.687306 |
| 2016-02-25 | 0.340000 | 0.624125 |
| 2015-11-13 | 0.340000 | 0.623223 |
| 2015-08-18 | 0.340000 | 0.526802 |
| 2015-05-15 | 0.340000 | 0.606742 |
| 2015-02-17 | 0.340000 | 0.644705 |
| 2014-11-13 | 0.321000 | 0.610524 |
| 2014-08-19 | 0.353000 | 0.731107 |
| 2014-05-16 | 0.347000 | 0.766844 |
| 2014-02-20 | 0.345000 | 0.793389 |
| 2013-11-18 | 0.326000 | 0.952985 |
| 2013-08-16 | 0.322000 | 0.905297 |
| 2013-05-16 | 0.320000 | 0.909175 |
| 2013-02-19 | 0.310000 | 0.924427 |
| 2012-11-13 | 0.257000 | 0.751100 |
| 2012-08-13 | 0.249000 | 0.710622 |
| 2012-05-17 | 0.261000 | 0.786111 |
| 2012-02-23 | 0.267000 | 0.705123 |
| 2011-11-09 | 0.219000 | 0.638486 |
| 2011-08-04 | 0.235000 | 0.677403 |
| 2011-05-19 | 0.232000 | 0.552504 |
| 2011-02-10 | 0.215000 | 0.500659 |
| 2010-11-08 | 0.193000 | 0.457877 |
| 2010-08-02 | 0.181000 | 0.436540 |
| 2010-05-10 | 0.188000 | 0.386205 |
| 2010-02-19 | 0.186000 | 0.386224 |
| 2009-11-06 | 0.158000 | 0.371602 |
| 2009-08-03 | 0.154000 | 0.352796 |
| 2009-05-08 | 0.145000 | 0.405398 |
| 2009-02-23 | 0.148000 | 0.403858 |
| 2008-11-07 | 0.117000 | 0.340692 |
| 2008-08-01 | 0.130000 | 0.350482 |
| 2008-05-13 | 0.131000 | 0.363998 |
| 2008-02-15 | 0.125000 | 0.333050 |
| 2007-11-02 | 0.101000 | 0.287275 |
| 2007-08-10 | 0.092000 | 0.266702 |
| 2007-05-10 | 0.098000 | 0.320838 |
| 2007-02-16 | 0.094000 | 0.314584 |
| 2006-11-10 | 0.079000 | 0.316199 |
| 2006-08-11 | 0.078000 | 0.286676 |
| 2006-05-12 | 0.077000 | 0.260883 |
| 2006-03-06 | 0.072000 | 0.221269 |
| 2005-11-10 | 0.064000 | 0.205968 |
| 2005-08-11 | 0.067000 | 0.260850 |
| 2005-05-05 | 0.069000 | 0.279756 |
| 2005-02-17 | 0.069000 | 0.329002 |
| 2004-11-09 | 0.051000 | 0.258060 |
| 2004-08-09 | 0.050000 | 0.230008 |
| 2004-05-10 | 0.049000 | 0.203026 |
| 2004-02-20 | 0.050500 | 0.201894 |
| 2003-11-13 | 0.036500 | 0.165483 |
| 2003-08-08 | 0.037500 | 0.176693 |
| 2003-05-08 | 0.037000 | 0.204377 |
| 2003-02-24 | 0.034000 | 0.240380 |
| 2003-01-07 | 0.017500 | 0.116392 |
| 2002-11-07 | 0.022500 | 0.159380 |
| 2002-08-19 | 0.022750 | 0.172836 |
| 2002-05-20 | 0.022000 | 0.176631 |
| 2002-02-15 | 0.023250 | 0.204743 |
| 2001-11-16 | 0.016000 | 0.144743 |
| 2001-08-20 | 0.016000 | 0.118057 |
| 2001-05-17 | 0.016250 | 0.155558 |
| 2001-03-08 | 0.016500 | 0.149125 |
| 2000-11-16 | 0.013750 | 0.115949 |
| 2000-08-24 | 0.014000 | 0.113832 |
| 2000-05-19 | 0.013500 | 0.150637 |
| 1999-11-04 | 0.006625 | 0.139708 |
| 1999-08-18 | 0.006875 | 0.153965 |
| 1999-05-21 | 0.006875 | 0.144222 |
| 1999-03-08 | 0.007250 | 0.174995 |
| 1998-11-20 | 0.008125 | 0.200079 |
| 1998-11-16 | 0.008125 | 0.199804 |
| 1998-08-21 | 0.008125 | 0.221922 |
| 1998-05-21 | 0.008125 | 0.208591 |
| 1998-03-12 | 0.008500 | 0.216279 |
| 1997-11-20 | 0.008500 | 0.185446 |
| 1997-08-25 | 0.008500 | 0.165667 |
| 1997-05-23 | 0.007500 | 0.137015 |
| 1997-03-07 | 0.006500 | 0.109330 |
| 1996-11-20 | 0.006250 | 0.149341 |
| 1996-08-26 | 0.006250 | 0.185596 |
| 1996-05-23 | 0.006250 | 0.142962 |
| 1996-03-07 | 0.006250 | 0.160101 |
| 1995-11-20 | 0.006250 | 0.166464 |
| 1995-08-14 | 0.006250 | 0.165901 |
| 1995-05-17 | 0.008125 | 0.261207 |
| 1995-03-07 | 0.006500 | 0.255302 |
| 1994-11-15 | 0.006000 | 0.249669 |
| 1994-08-09 | 0.006250 | 0.245285 |
| 1994-03-08 | 0.005250 | 0.189354 |
| 1993-11-17 | 0.004625 | 0.167031 |
| 1993-08-17 | 0.004625 | 0.201349 |
| 1993-05-18 | 0.004375 | 0.206125 |
| 1993-04-07 | 0.002500 | 0.129446 |
| 1992-11-17 | 0.002500 | 0.169590 |
| 1992-08-18 | 0.003125 | 0.264285 |
| 1992-05-19 | 0.002625 | 0.232497 |
| 1992-03-03 | 0.002188 | 0.183085 |
| 1991-11-20 | 0.002188 | 0.284437 |
| 1991-08-21 | 0.002188 | 0.267354 |
| 1991-05-20 | 0.002500 | 0.379376 |
| 1991-03-05 | 0.002500 | 0.393883 |
| 1990-11-20 | 0.002313 | 0.439313 |
| 1990-08-17 | 0.002313 | 0.470815 |
| 1990-05-21 | 0.002188 | 0.457267 |
| 1990-03-08 | 0.002375 | 0.497897 |
| 1989-11-20 | 0.001938 | 0.389543 |
| 1989-08-16 | 0.001875 | 0.436012 |
| 1989-05-22 | 0.001938 | 0.503778 |
| 1989-03-09 | 0.002313 | 0.782262 |
| 1988-12-06 | 0.001875 | 0.649467 |
| 1988-09-08 | 0.002250 | 0.813753 |
| 1988-06-10 | 0.001750 | 0.683493 |
| 1988-04-12 | 0.001875 | 0.647217 |
| 1988-02-08 | 0.001875 | 0.878000 |
| 1987-10-23 | 0.001875 | 0.642399 |
| 1987-07-09 | 0.002375 | 0.535077 |
| 1987-06-22 | 0.001875 | 0.414179 |
| 1987-02-23 | 0.001875 | 0.510209 |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.4342599 |
| Address1 | 124 Dvora HaNevi’a St. |
| All Time High | 72.31 |
| All Time Low | 0.0625 |
| Ask | 32.95 |
| Ask Size | 500 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 4,368,250 |
| Average Daily Volume3 Month | 7,836,455 |
| Average Volume | 7,836,455 |
| Average Volume10Days | 4,368,250 |
| Beta | 0.764 |
| Bid | 31.94 |
| Bid Size | 800 |
| Book Value | 6.879 |
| City | Tel Aviv-Yafo |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 32.4 |
| Current Ratio | 1.036 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 32.81 |
| Day Low | 31.27 |
| Debt To Equity | 217.715 |
| Display Name | Teva Pharmaceutical Industries |
| Dividend Date | 1,513,036,800 |
| Earnings Call Timestamp End | 1,777,464,000 |
| Earnings Call Timestamp Start | 1,777,464,000 |
| Earnings Timestamp | 1,777,465,800 |
| Earnings Timestamp End | 1,777,465,800 |
| Earnings Timestamp Start | 1,777,465,800 |
| Ebitda | 4,953,999,872 |
| Ebitda Margins | 0.28706 |
| Enterprise To Ebitda | 10.281 |
| Enterprise To Revenue | 2.951 |
| Enterprise Value | 50,931,937,280 |
| Eps Current Year | 2.67928 |
| Eps Forward | 3.11595 |
| Eps Trailing Twelve Months | 1.21 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,511,740,800 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 31.6294 |
| Fifty Day Average Change | 0.7706013 |
| Fifty Day Average Change Percent | 0.024363449 |
| Fifty Two Week Change Percent | 143.426 |
| Fifty Two Week High | 37.35 |
| Fifty Two Week High Change | -4.949997 |
| Fifty Two Week High Change Percent | -0.13253005 |
| Fifty Two Week Low | 13.04 |
| Fifty Two Week Low Change | 19.36 |
| Fifty Two Week Low Change Percent | 1.4846627 |
| Fifty Two Week Range | 13.04 - 37.35 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 382,717,800,000 |
| Five Year Avg Dividend Yield | 2.95 |
| Float Shares | 1,069,406,482 |
| Forward Eps | 3.11595 |
| Forward P E | 10.398113 |
| Free Cashflow | 2,031,500,032 |
| Full Exchange Name | NYSE |
| Full Time Employees | 31,173 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.5179 |
| Gross Profits | 8,938,000,384 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.000030000001 |
| Held Percent Institutions | 0.60178 |
| Implied Shares Outstanding | 1,192,976,781 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Dividend Date | 1,511,740,800 |
| Last Dividend Value | 0.085 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,088,640,000 |
| Last Split Factor | 2:1 |
| Long Business Summary | Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. |
| Long Name | Teva Pharmaceutical Industries Limited |
| Market | us_market |
| Market Cap | 38,652,448,768 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_308047 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 1,410,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 36,386,629,328 |
| Number Of Analyst Opinions | 11 |
| Open | 31.3 |
| Operating Cashflow | 1,648,999,936 |
| Operating Margins | 0.27277002 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.61 |
| Phone | 972 3 914 8213 |
| Previous Close | 31.26 |
| Price Eps Current Year | 12.092801 |
| Price Hint | 2 |
| Price To Book | 4.709987 |
| Price To Sales Trailing12 Months | 2.239683 |
| Profit Margins | 0.0817 |
| Quick Ratio | 0.54 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.46154 |
| Region | US |
| Regular Market Change | 1.14 |
| Regular Market Change Percent | 3.64684 |
| Regular Market Day High | 32.81 |
| Regular Market Day Low | 31.27 |
| Regular Market Day Range | 31.27 - 32.81 |
| Regular Market Open | 31.3 |
| Regular Market Previous Close | 31.26 |
| Regular Market Price | 32.4 |
| Regular Market Time | 1,776,456,003 |
| Regular Market Volume | 4,041,355 |
| Return On Assets | 0.061690003 |
| Return On Equity | 0.20786 |
| Revenue Growth | 0.114 |
| Revenue Per Share | 15.072 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,164,403,205 |
| Shares Percent Shares Out | 0.0232 |
| Shares Short | 27,042,748 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 32,527,649 |
| Short Name | Teva Pharmaceutical Industries |
| Short Percent Of Float | 0.0234 |
| Short Ratio | 3.44 |
| Source Interval | 15 |
| Symbol | TEVA |
| Target High Price | 45.0 |
| Target Low Price | 28.0 |
| Target Mean Price | 38.18182 |
| Target Median Price | 40.0 |
| Total Cash | 3,556,000,000 |
| Total Cash Per Share | 3.093 |
| Total Debt | 17,230,000,128 |
| Total Revenue | 17,258,000,384 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.21 |
| Trailing P E | 26.77686 |
| Trailing Peg Ratio | 1.6127 |
| Triggerable | 1 |
| Two Hundred Day Average | 25.0829 |
| Two Hundred Day Average Change | 7.3171024 |
| Two Hundred Day Average Change Percent | 0.29171678 |
| Type Disp | Equity |
| Volume | 4,041,355 |
| Website | https://www.tevapharm.com |
| Zip | 6,944,020 |